Statistics
Publications
3
Citations
322
H-Index
3
Active since
2021
Tingxue Xie is an author at First Affiliated Hospital Zhejiang University specializing in pd-l1 blockade, immunotherapy, and checkpoint inhibitor therapy.
Publications per year
2021–2024
3
3
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
Youqian Wu, Chao Zhang, Xiao‐Lan Liu et al. · Nature Communications · 2021 · 114 citations · Full text
Medicine, Oncology, Pharmacology +17
Hsc70 promotes anti-tumor immunity by targeting PD-L1 for lysosomal degradation
Xiaoyan Xu, Tingxue Xie, Mengxin Zhou et al. · Nature Communications · 2024 · 44 citations · Full text
Life Sciences, Immunology, Oncology +17
1–3 of 3